Abstract HTLV-1 is a human retrovirus that is associated with the neuroinflammatory disorder HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). In these patients, HTLV-1 is primarily found in the CD4 +
Introduction
Human T cell Lymphotropic Virus-1 (HTLV-1) is a human retrovirus initially isolated in 1980 from a patient with a cutaneous T cell lymphoma (Poiesz et al. 1980) . It is estimated that 15-20 million people worldwide are infected, though the vast majority will remain asymptomatic carriers (Proietti et al. 2005; Osame et al. 1986 ). Approximately 0.25-4 % will develop HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) with another 1-5 % developing Adult T cell leukemia/ lymphoma (ATLL) (Proietti et al. 2005) . HAM/TSP is a neuroinflammatory disorder characterized by perivascular inflammatory infiltration in the brain and spinal cord (Izumo 2010) . Activated cytotoxic T cells (CD8 + T cells) and the production of inflammatory cytokines, including IFN-γ and TNF-α, have been associated with damage to the central nervous system (CNS) (Barmak et al. 2003) , eventually leading to urinary and bowel incontinence, spastic limb paraparesis, parasthesias and ataxia manifesting after a long asymptomatic phase of infection (Evangelou et al. 2012) . In all HTLV-1 infected individuals the primary viral reservoir is CD4 + CD25 + T cells (Yamano et al. 2004) , a subset of which is comprised of regulatory T cells (Tregs) . Given that Treg dysfunction has been reported in HAM/TSP patients , proper characterization of Tregs and their functional abnormalities may provide an assessment of the immune dysregulation observed in HAM/TSP patients and serve as a valuable biomarker in clinical trials.
Tregs are essential in maintaining peripheral immune tolerance through their ability to actively suppress auto-reactive T cells and other inflammatory immune responses (Sakaguchi 2005) . They have been implicated in cancer, infectious disease, autoimmunity, transplant medicine and allergy, but their characterization and isolation has proven to be complex (Balandina et al. 2005; Chen et al. 2007; Weiss et al. 2012) . Although the cell surface markers CD4 and CD25 are rout i n e l y u s e d f o r th e i r i s o l a t i o n , i n h u m a n s t h e CD4 + CD25 + subset also includes activated T cells. Notably, only the top 1-2 % of these cells (CD4 + CD25 hi ) is considered to be functionally suppressive (Baecher-Allan et al. 2001) , and this frequency varies physiologically, especially with increased age (Gregg et al. 2005) . Several additional markers used to characterize Tregs in healthy donors, including GITR, CD127, and CTLA4, are unreliable here due to their alteration by HTLV-1 related activation (Ramirez et al. 2010; Michaelsson et al. 2008) .
FoxP3 was first identified as a specific Treg marker in the context of the genetic disorder Immunodysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX) in which the gene is mutated (Wildin et al. 2001) . IPEX patients develop life-threatening autoimmune complications due to a defect in Tregs (van der Vliet and Nieuwenhuis 2007). Furthermore, when CD4 +
CD25
-T cells (Teffs) were induced to express FoxP3, they acquired a Treg phenotype indicating that FoxP3 is a Treg lineage specific factor (Loser et al. 2005) . However, in the human immune system, the FoxP3 expressing subset includes many cell types (i.e. natural, induced, naive, memory, etc.) with different functions and FoxP3 expression levels (Miyara et al. 2009 ). Additionally, there is up-regulation of FoxP3 transiently upon activation of T cells ). Therefore, in inflammatory disorders such as HAM/TSP, Foxp3 expression may not be a reliable marker of Tregs.
Recent research has highlighted the importance of DNA methylation in the epigenetic control of Foxp3 gene expression (Bettini et al. 2012; Lal and Bromberg 2009) . Studies have shown that selective demethylation of a conserved CpG island within the Foxp3 locus termed the Treg-specific demethylated region (TSDR) leads to stable Foxp3 expression and defines thymic-derived natural Tregs (Toker and Huehn 2011) . On the other hand, activated T cells and peripherallyinduced Tregs (iTregs) exhibit a variably methylated FoxP3 TSDR (Baron et al. 2007) . Importantly, stable expression of FoxP3 through demethylation of the TSDR is necessary for Treg suppression (Polansky et al. 2010 
+ subset of our HAM/TSP patients may also serve as an indicator of disease progression and suggests that a virus or viral gene may contribute to dysregulation of Tregs.
Materials and Methods

Patient Samples
A total of 10 ND PBMCs and 9 HAM/TSP PBMCs samples were used for this study. An additional 3 ND PBMC samples and 6 HAM/TSP samples were used for 24 h PBMC culture. ND ranged from 28 to 64 years old while HAM/TSP patients ranged from 31 to 70 years old. PBMCs were isolated by Ficoll-Hypaque (Lonza, Walkersville, MD) centrifugation, and were cryopreserved in liquid nitrogen until use. All NDs were noted to be healthy and HTLV-1 negative. The study was reviewed and approved by the National Institute of Neurological Disorders and Stroke Institutional Review Board. Informed consent was written and obtained from each subject in accordance with the Declaration of Helsinki.
Cell Lines HTLV-1-infected human cell lines HUT102 and MT2 and the uninfected cell lines Jurkat and MOLT3 were used. All the cells were cultured in RPMI 1640 supplemented with 10 % FBS, 100 U/mL penicillin, 100 μg/mL streptomycin sulfate, and 2 mM L-glutamine in 5 % CO 2 incubator at 37°C.
DNA Isolation
Total DNA was isolated from cell lines or cells obtained from NDs and HAM/TSP patients using the DNeasy Blood and Tissue Kit (Qiagen, Germantown, MD). All samples were incubated with RNAse A at 37°C for 30 min to ensure removal of all RNA.
Bisulfite Conversion
Due to the harshness of the reaction, at least 1 μg of DNA was utilized when possible. All samples were initially cut with Fast Digest EcoRI (Fermentas, Glen Burnie, MD).
Bisulfite conversions were completed using the Cells-toCpG kit (Applied Biosystems, Foster City, CA) according to the manufacturer's instructions.
Quantitative PCR
Bisulfite converted DNA was amplified in two separate reactions on a ViiA7 thermocycler (Applied Biosystems, Foster City, CA). One reaction amplied demethylated FoxP3 and the other amplified methylated FoxP3 using primers and probes directed against FoxP3 intron1 (Stockis et al. 2009 ). The reactions occurred in a total volume of 20 μl with 5 μl of bisulfite converted DNA. The thermal cycler conditions were as follows: 50°C for 2 min, 95°C for 10 min, 40 cycles at 95°C for 15 s (denaturation) and 60°C for 1 min (annealing and extension), and 25°C for 2 min. The level of demethylation was calculated as published previously (Stockis et al. 2009 ) and values from female patients were doubled to account for 2 X chromosomes.
Flow Cytometry
For analysis of CD4 + T cell population, cells were stained with CD3-APC-Cy7, CD4-PE-Cy7, and CD25-PE (BD Bioscience, San Jose, CA) and then fixed with Fixation Buffer (eBioscience, San Diego, CA) following their supplied protocol. After washing the cells with permiabilization buffer (eBioscience), FoxP3 antibody (236A/E7; eBioscience) was added to cells for the intracellular staining. Monoclonal isotype controls were used for each antibody and set as the negative control. Flow cytometric analysis was performed using a LSRII (BD Biosciences). All data were analyzed using FlowJo software (Tree Star, San Carlos, CA). 
CD4
CD25
-cells. Purity was assessed by flow cytometry using an CD25-PE antibody (BD Biosciences clone M-A251). The results in this study on levels of FoxP3 TSDR demethylation was adjusted (normalized) to the purity of the CD4 + CD25
+ T cell bead isolation from each patient (that ranged from 50.7 to 90.6 % mean = 65.5 in HAM/TSP and 22.7-80.1 % mean = 53.03 in ND, p = NS).
Suppression Assays
Suppressive function of Tregs in ND and HAM/TSP patients was assessed by inhibitory effects of allogeneic cell proliferation. CD4 + CD25 + T cells were magnetically isolated from 3 ND and 2 HAM/TSP patients. 2.5 μM CFSE (Invitrogen Life Technologies, Carlsbad, CA) was integrated into Teffs isolated from the same ND for each experiment. Teffs were added at 2×10 4 cells in 96 Ubottom microplates containing varying amounts of irradiated Tregs for final ratio of Treg:Teff of 0.25:1 to 1:1, 500 ng/mL anti-CD3 HIT3a (BD Biosciences) and 5×10 4 cells of autologous irradiated ND PBMCs (used as feeder cells) in 5 % Human AB serum in RPMI 1640 with 100 U/mL penicillin, 100 μg/mL streptomycin sulfate, and 2 mM L-glutamine. PBMC and Tregs were gamma irradiated to 3000 rad using a Cs irradiation source. After culture for 3 days, cells were stained with CD3-APC, CD4-Alexa700, and CD-25PE (BD Biosciences) and then analyzed on LSRII for proliferation. Cells stained with monoclonal isotype antibodies were used as negative controls.
Tax and HBZ mRNA Quantification
Total RNA was extracted from PBMCs using RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions. 85 ng of total RNA was converted into cDNA and amplified in a one step reaction using TaqMan® RNA-to-CtTM 1-Step Kit (Applied Biosystems) according to the manufacturer's instructions. Tax primer and probe sequences (Oh et al. 2005) or HBZ primer probe (Enose-Akahata et al. 2013) were added to mRNA samples and amplified on a Viia7 (Applied Biosystems) thermocycler as follows: 48°C for 15 min, 95°C for 10 min, and 45 cycles at 95°C for 15 s and 60°C for 1 min. HPRT primers and probe were added to mRNA for an assessment of RNA quantity and quality on samples in each run. MT-2 was used as a calibrator sample and the level of tax and HBZ mRNA expression was then calculated using the comparative CT method on ViiA 7 software.
Tax Expression 6 HAM/TSP and 3 ND PBMCs were incubated at 37°C in RPMI 10 %FBS for 24 h to allow for peak expression of HTLV-1 Tax (Rende et al. 2011) . Cells were then stained with CD3-Pacific Blue, CD4-PECy7, CD25-PE, CD8-PerCp5.5 (BD Biosciences) for cell surface staining. FoxP3-APC (eBioscience), and Lt-4-Alexa Flour® 488 were added for intracellular staining according to the manufacturer's protocol. Cells were also stained with monoclonal isotype control antibodies as negative controls and analyzed on LSRII for staining intensity. PBMCs were collected before and after culture to extract total DNA and then analyze FoxP3 TSDR demethylation.
Proviral Load
Proviral load was determined from DNA using the same tax primers and probes mentioned previously (Oh et al. 2005) (Toker and Huehn 2011; Sahin et al. 2013 ). In NDs, 2.066 % (s.d.+/− 0.154 %) of FoxP3 TSDR demethylation was detected in whole PBMCs (Fig. 1a) . A significant increase in demethylation was detected in the total CD4 + T cell (8.097 %) population and even higher in the isolated CD4
+ CD25 + T cell subset (60.15 %) compared to whole PBMCs (p = 0.0004 and p < 0.0001, respectively; Fig. 1b) . Thus, the enrichment of CD4 + CD25 + T cells from whole PBMC significantly increases the percentage of FoxP3 TSDR demethylation and is consistent with previous studies (Liu et al. 2010) .
Since the frequency of CD4 + CD25 + T cells is known to be elevated in HAM/TSP patients compared to NDs (Mukae et al. 1994) , it was important to incorporate this when measuring FoxP3 TSDR methylation. As shown in Fig. 1c, + T cells as compared to NDs (p=0.0339; Fig. 1d) . A similar trend was also observed in whole PBMCs although this relationship did not reach statistical significance (p= 0.1659; Fig. 1e ) probably due to the low frequency of CD4 + CD25
+ cells in PBMCs (Fig. 1c) .
No Correlation Between the Percent FoxP3 + Cells and FoxP3 Demethylation
Many investigators have relied upon FoxP3 by flow cytometry for characterization of Tregs (Miyara et al. 2009 ). Although in NDs it appears to be a reliable marker, FoxP3 can also be increased upon T cell activation ). FoxP3 mRNA and protein has been demonstrated to be decreased in HAM/TSP patients, although this was demonstrated in isolated T cell subsets (Oh et al. 2006 Fig. 2a ). In particular, the percent FoxP3 + cells in PBMCs and the level of FoxP3 TSDR demethylation did not correlate in our experiments (p=0.2765, r 2 =0.0692; Fig. 2b ). These results are likely due to transient expression of FoxP3 in activated T cells, which are increased in HAM/TSP patients compared to NDs (Yamano et al. 2009 + T cells were able to suppress allogeneic activated ND Teffs and this suppressive capacity increased depending on Treg:Teff ratio (Fig. 3a-c ). In contrast, HAM/TSP patients CD4 + CD25 + T cells suppressed to a significantly lesser extent, especially at high Treg:Teff (1:1) (p =0.0041; Fig. 3c ). A two-way ANOVA analysis demonstrated a significant difference in suppression when assessing both patient type (HAM/TSP vs. ND) and Treg:Teff ratio. In addition, there was a trend (with 2 NDs and 2 HAM/TSP patients) for the level of demethylation in the FoxP3 TSDR to positively associate with the level of suppression. These results demonstrated that the decrease of Treg suppressive function in HAM/TSP patients may be associated with the demethylation status of FoxP3 TSDR.
FoxP3 Demethylation in HTLV-1 CD4 + T Cell Lines
Initially, HTLV-1-infected and uninfected cell lines were characterized for expression of virus specific gene products, Treg markers (CD25 and FoxP3) and the demethylation levels of the FoxP3 TSDR. Both HTLV-1-infected cell lines MT2 and HUT102 express CD25 (95.7, 96.5 % respectively) (Fig. 4a) while the HTLV-1-uninfected cell lines Jurkat and MOLT-3 were CD25 negative (Fig. 4a) . Only MT2 expressed a high percentage of 
FoxP3
+ cells in the CD25 + T cell population (97.6 %) (Fig. 4a) . In contrast, HUT102 had very few CD25 + FoxP3 + cells (1.3 %) (Fig. 4a) . The two uninfected CD25 -T cell lines had low levels of FoxP3 positivity (Fig. 4a ) consistent with previous reports (Yagi et al. 2004) .
Given the variation of CD25 and the percent FoxP3 positivity in these cell lines, the level of FoxP3 TSDR demethylation was determined in each. The MT2 cell line, which had the highest percentage of FoxP3 by flow cytometry, had a FoxP3 TSDR that was completely demethylated, displaying similar levels of demethylation to that reported in natural thymus-derived Tregs from healthy donors (95-99.98 %) (Fig. 4b) (Janson et al. 2008) . By contrast, HUT102 was completely methylated (Fig. 4b) . Similarly, the two uninfected T cell lines that had low FoxP3 positivity by flow cytometry also displayed complete methylation.
Since HTLV-1 gene products including Tax and HTLV-1 basic leucine zipper factor (HBZ) have previously been suggested to interact with FoxP3 (Grant et al. 2008; Satou et al. 2011) , we next determined if FoxP3 methylation status was associated with expression of these viral proteins. Since MT-2 expressed both tax and HBZ mRNA, all the data was normalized to tax and HBZ mRNA expressions in MT-2 as 1.00. When compared to MT-2, HUT102 expressed more tax mRNA (12.24 times) but had lower HBZ mRNA levels ( Fig. 4c and d) , as previously reported (Satou et al. 2006) . As expected, tax and HBZ mRNA were not detected in Jurkat and MOLT3, the two HTLV-1-uninfected cell lines. Thus, tax mRNA expression levels were elevated in the HTLV-1-infected cell line that had complete FoxP3 TSDR methylation (HUT 102, Fig. 4b ). By contrast, the MT2 cell line which had lower levels of tax expression had a completely demethylated FoxP3 TSDR. Since both HTLV-1 infected T cell lines expressed HTLV-1 HBZ, there appeared to be no relationship with FoxP3 TSDR methylation.
Negative Correlation of FoxP3 TSDR Demethylation with HTLV-1 Tax Expression HTLV-1 Tax is a pleiotropic viral protein that transactivates a number of cellular pathways, directly regulates interleukin production, promotes IL-2 independent growth in infected T cells, and impacts gene expression through chromatin remodeling (Currer et al. 2012) . HAM/TSP patients are known to + TSDR % demethylation and suppressive capacity as determined in lymphoproliferation suppression assays at Treg:Teff ratio of 1:1 express more of this viral gene than asymptomatic carriers (AC) (Nagai et al. 1998) . Moreover, Tax has previously been shown to decrease FoxP3 levels after transfection into ND CD4 + CD25 + T cells . We therefore asked if there was also a correlation with increased HTLV-1 Tax expression in HAM/TSP CD4 + CD25 + T cells and decreased FoxP3 TSDR demethylation.
Freshly thawed PBMCs do not express HTLV-1 Tax at baseline by flow cytometry (Fig. 5a) , however, after shortterm culture (24 h), variable levels of Tax expression were observed, particularly in the CD4 + CD25 + T cell subset (Fig. 5a ). Proof of concept was performed by observing FoxP3 demethylation before and after culture in isolated CD4 + T cells from 2 HAM/TSP patients. Both showed a significant decline in FoxP3 TSDR demethylation after culture. Increasing levels of HTLV-1 Tax in CD4   +   CD25 + HAM/ TSP T cells had a strong linear correlation (Coefficient of determination r 2 =0.7736, p=0.0145; Fig. 5b ) with a decline in the FoxP3 TSDR demethylation from HAM/TSP PBMC. This decreased FoxP3 TSDR demethylation in HAM/TSP also correlated with the levels of HTLV-1 tax mRNA expression in PBMC after 24 h culture (unpublished observations). As controls, there were no changes in FoxP3 TSDR demethylation in short-term cultures of ND PBMCs that were HTLV-1 Tax negative (Fig. 5b, circled points) . To assess for the possibility that the decline in FoxP3 TSDR demethylation may be attributed to Treg death via CD8 + cytotoxic T cell killing, two of our patient samples were depleted of CD8 + T cells by bead isolation. As shown in Fig. 5c , in the absence of CD8 + T cells, both patients still demonstrated a large decline in FoxP3 TSDR demethylation post-culture that mirrored a concomitant increase in tax mRNA expression (Fig. 5c ).
Discussion
Immune dysregulation is a prominent feature in HTLV-1-associated disorders, although how the virus contributes to this outcome remains incompletely understood. Of particular interest, HAM/TSP patients display an activated inflammatory immune response associated with a decreased suppressive capacity in Treg cells (Nishiura et al. 1996) . In contrast, it has been demonstrated that the immunocompromised state seen in ATLL patients may be a result of clonal expansion of a Treg precursor, suppressing anti-tumor immunity (Yano et al. 2007 ). Flow cytometry, has been used to characterize these Tregs, based on a number of cell surface markers and intracellular expression of FoxP3. However many of these same markers, including FoxP3, are also seen on activated T cells ). Furthermore, the use of FoxP3 as a Treg lineage specific marker has been difficult due to the heterogeneity in phenotype and function within the human FoxP3 subset (d'Hennezel et al. 2011) .
FoxP3 TSDR methylation status has been suggested to be a better indicator of sustained Treg suppressive function, particularly in inflammatory environments (Polansky et al. 2008) . Recently, it has been demonstrated that FoxP3 TSDR demethylation can be characterized from whole blood PBMCs if used in conjunction with normalization to a specific T cell population (Barzaghi et al. 2012) . We took a similar approach by enumerating demethylation of the FoxP3 TSDR in i) PBMCs; ii) CD4 + T cells; iii) CD4 + CD25 + T cells of HAM/TSP patients normalized to the activated CD4 + T cell population as determined by flow cytometry. Since HAM/TSP patients have a higher percentage of CD4 + CD25 + T cells (Fig. 1c ) reflective of the activated T cell population known to be elevated in this disease (Mukae et al. 1994; Yamano et al. 2009) + T cells with higher levels of FoxP3 TSDR demethylation (Fig. 4) and a trend of an association with the level of FoxP3 TSDR demethylation with Treg suppression (Fig. 3) . While additional patients and TSDR demethylation before and after culture for 24 h. ND samples are circled in red. Coefficient of determination r 2 =0. 7736 (c) %FoxP3 TSDR demethylation and tax mRNA expression in isolated HAM/TSP CD4 + T cells ex vivo controls will be required to confirm this observation, these results suggest that FoxP3 TSDR demethylation may be a good surrogate for Treg functional suppressive capacity. In addition, it would be of interest to compare FoxP3 levels, as assessed by FoxP3 protein expression or MFI analysis by flow, with Treg suppression. This dysregulation of Tregs may foster a proinflammatory environment that contributes to the pathogenesis of HAM/TSP (Grant et al. 2008) .
The results in this study are consistent with previous reports demonstrating decreased Treg function in HAM/TSP ) though it had been unclear if this is due to a decreased Treg population, Treg function or both. Since it had been shown that the expression of an HTLV-1 tax was associated with a decrease in FoxP3 expression ) and that HTLV-1 Tax increases after short-term in vitro culture of HAM/TSP PBMC (Rende et al. 2011 ), we asked if there was also a correlation between the HTLV-1 proviral load and the observed decrease in FoxP3 TSDR demethylation. The observation of decreased FoxP3 demethylation in vitro concurrently with increasing Tax expression led us to believe that these changes in demethylation are a direct consequence of HTLV-1 protein expression since Tax expression did not affect the population of CD4 + CD25 + T cells after culture (unpublished observation). Furthermore, the reduction of FoxP3 demethylation in isolated CD4 + T cells (Fig. 5c ) in the absence of cytotoxic T cells suggests a direct effect of Tax on FoxP3 expression rather than cytotoxic T cell mediated lysis of the Treg population. We conclude that the observed dysregulation of Tregs in HAM/TSP is associated with a decrease in Treg function rather than Treg numbers and suggest that this inhibition of Treg function is mediated by the trans-activating properties of the HTLV-1 tax gene.
HAM/TSP patients are known to express higher levels of tax mRNA compared to asymptomatic carriers (Nagai et al. 1998 ). Additionally, we have shown that the HUT102 cell line that had higher levels of tax expression compared to MT2 was associated with a completely methylated TSDR (Fig. 4) . Collectively, these observations on the ex vivo association of reduced Fox P3 TSDR demethylation and high HTLV-1 tax expression coupled with the in vitro correlates of Tax expression with decreased demethylation supports the potential role for HTLV-1 tax in the dysregulation of the FoxP3 TSDR methylation in HAM/TSP.
Since we have shown that increased virus protein expression was associated with decreased FoxP3 TSDR demethylation, we asked if this also correlated with clinical outcome measures in HAM/TSP. Of the three patients with the largest decrease in FoxP3 TSDR demethylation (patients 1-3 in Table 1 ) two had high clinical disability scores (IPEC >13). Patients 1 and 2 also had rapid clinical deterioration and shorter duration of disease. Patient 3 had multiple brain lesions on MRI that have progressed since disease onset. Although proviral load correlated with HTLV-1 Tax expression after short-term culture (unpublished observation), it did not correlate with FoxP3 TSDR demethylation. This may be due to measurement of proviral load in whole PBMCs rather than in the main HTLV-1 peripheral reservoir, CD4 + CD25 + T cells. However, if decreased FoxP3 TSDR demethylation is confirmed to be associated with poorer clinical outcome measures in larger cohorts of HAM/TSP patients, this would not only support dysregulation of Tregs as an immunopathological mechanisms in HTLV-1 neurologic disease Grant et al. 2008 ) but would also introduce potential therapeutic strategies that target epigenetic modification of Treg cells. Many studies have utilized demethylating agents such as 5-aza-2′-deoxycytydine (DAC) and procainamide to demethylate the TSDR in Teffs, thereby transforming them into functionally suppressive Tregs (Zheng et al. 2009; Blanco et al. 2009 ). Similar agents such as 5-azacytidine and valproate have been explored in HTLV-1 infection but only for their potential anti-retroviral and anti-leukemic properties (Belrose et al. 2011; Diamantopoulos et al. 2012) . To date, no one has explored their use in restoring Treg function in HAM/TSP. In summary, the results in this study support the observation that HAM/TSP patients have decreased demethylation in the FoxP3 TSDR that associated with reduced Treg function. These changes in the TSDR appear to be related to HTLV-1 Tax expression in vitro and might inform clinical status in HAM/TSP patients. FoxP3 TSDR methylation status may also serve as a good surrogate biomarker for Treg function in conjunction with other disease parameters in HTLV-1 infected patients. Moreover, these observations provide for a new avenue of therapeutic interventional strategies that may be beneficial to patients with HAM/TSP.
